• Health

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76

January 14, 2025 16:58 ET  | Source: Context Therapeutics Inc. CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers…